Global Blood Therapeutics is dedicated to improving the care of people living with Sickle Cell Disease, a rare or orphan disease affecting primarily the black community.
RIESTER RX developed a successful unbranded disease awareness and education campaign for Global Blood Therapeutics while also supporting branded initiatives to promote the novel treatment for Sickle Cell, Oxbryta.
Global Blood Therapeutics
Global Blood Therapeutics
"*" indicates required fields